Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ADA-SCID with 'WAZA-ARI' mutations that synergistically abolished ADA protein stability.

British journal of haematology - 1 Jun 2011

Okura Yuka, Yamada Masafumi, Kobayashi Ichiro, Santisteban Ines, Arredondo-Santisteban Gabriella, Kato Zenichiro, Iguchi Akihiro, Yoshida Makoto, Ohara Osamu, Nakagawa Noriko, Imai Kohsuke, Hershfield Michael S, Ariga Tadashi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Deaminase
Share to Fatal Outcome
Share to Infant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pedigree

Share to Protein Stability

Share to Protein Structure, Tertiary

Share to Severe Combined Immunodeficiency

Source

Identifiers

PMID: 21410451
DOI: 10.1111/j.1365-2141.2011.08640.x

Genes

ADA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ADA-SCID with 'WAZA-ARI' mutations that synergistically abolished ADA protein stability.PMID 21410451Read ↗

HSCT cures ADA2 deficiency.Semantic proximity Read ↗

Twenty-Five Years of Gene Therapy for ADA-SCID: From <i>Bubble Babies</i> to an Approved DrugSemantic proximity Read ↗

Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical ManifestationsSemantic proximity Read ↗

Identification of two new missense mutations (R156C and S291L) in two ADA- SCID patients unusual for response to therapy with partial exchange transfusions.Semantic proximity Read ↗

Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.Semantic proximity Read ↗

Gene therapy for adenosine deaminase severe combined immune deficiency—An unexpected journey of four decadesSemantic proximity Read ↗

Homozygous Splice ADA2 Gene Mutation Causing ADA-2 Deficiency.Semantic proximity Read ↗

ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing AuthorizationSemantic proximity Read ↗

Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapySemantic proximity Read ↗

Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.Semantic proximity Read ↗

How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID)Semantic proximity Read ↗

Activation-induced deaminase, AID, is catalytically active as a monomer on single-stranded DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.